Chronic Kidney Disease
Study: Semaglutide slowed progression of CKD, cut cardiovascular events, mortality risk
Use of the drug semaglutide in patients with type 2 diabetes significantly reduced the risk of major kidney disease events, cardiovascular outcomes and all-cause mortality vs. placebo, newly published data show.
Men at higher risk for diabetes-related complications than women
Men were at greater risk for several complications associated with type 1 and type 2 diabetes compared with women, according to results published in the Journal of Epidemiology & Community Health.
Hydralazine-induced autoimmune conditions may include drug-induced lupus, vasculitis
LONG BEACH, Calif. — Hydralazine-induced autoimmune conditions may have a varied presentation, including drug-induced lupus or vasculitis, according to a speaker, here.
Serology ‘significantly different’ between membranous vs. proliferative lupus nephritis
Proteinuria levels are not predictive of membranous lupus nephritis vs. proliferative lupus nephritis, according to data published in Rheumatology.
Medical nutrition therapy seen as cost-effective, cost-saving method for late-stage CKD
LONG BEACH, Calif. — Implementing medical nutrition therapy for patients with late-stage chronic kidney disease saved an estimated $47,000 per patient by delaying the need for dialysis, according to a poster presented here.
Investigational drug that reduces hepcidin offers promise for treating anemia
LONG BEACH, Calif. — Researchers reported results from a phase 1b/2a placebo-controlled study of DISC-0974, an anti-hemojuvelin antibody to treat anemia in patients with chronic kidney disease.
Similar outcomes seen with chlorthalidone, hydrochlorothiazide among veterans
LONG BEACH, Calif. — Progression toward chronic kidney disease was similar in a Veterans Affairs Health Care System study of patients on either chlorthalidone or hydrochlorothiazide, according to a study presented here.
Lisa Koester, ANP, CS, CNN-NP, MSN, receives Carol Mattix Award
The National Kidney Foundation has awarded Lisa Koester, ANP, CS, CNN-NP, MSN, the Carol Mattix Award at the NKF Spring Clinical Meetings in Long Beach, California.
David M. Charytan, MD, MSc, receives J. Michael Lazarus Award
The National Kidney Foundation has awarded the J. Michael Lazarus Distinguished Award to David M. Charytan, MD, MSc.
Mitral regurgitation linked to heightened risk of CKD in patients with heart failure
LONG BEACH, Calif. — Patients with heart failure who also experienced mitral regurgitation saw a doubling of their creatinine, according to data presented here.